Translating dosages from animal models to human clinical trials—revisiting body surface area scaling
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Body surface area (BSA) scaling has been used for prescribing individualized dosages of various drugs and has also been recommended by the U.S. Food and Drug Administration as one method for using data from animal model species to establish safe starting dosages for first‐in‐human clinical trials. Although BSA conversion equations have been used in certain clinical applications for decades, recent recommendations to use BSA to derive interspecies equivalents for therapeutic dosages of drug and natural products are inappropriate. A thorough review of the literature reveals that BSA conversions are based on antiquated science and have little justification in current translational medicine compared to more advanced allometric and physiologically based pharmacokinetic modeling. Misunderstood and misinterpreted use of BSA conversions may have disastrous consequences, including underdosing leading to abandonment of potentially efficacious investigational drugs, and unexpected deadly adverse events. We aim to demonstrate that recent recommendations for BSA are not appropriate for animal‐to‐human dosage conversions and use pharmacokinetic data from resveratrol studies to demonstrate how confusion between the “human equivalent dose” and “pharmacologically active dose” can lead to inappropriate dose recommendations. To optimize drug development, future recommendations for interspecies scaling must be scientifically justified using physiologic, pharmacokinetic, and toxicology data rather than simple BSA conversion.—Blanchard, O. L., Smoliga, J. M. Translating dosages from animal models to human clinical trials—revisiting body surface area scaling. FASEB J. 29, 1629‐1634 (2015). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Concerning dosing, differences in metabolism, weight, distribution volume etc. result in different dosing, and oversimplified approaches for dose prediction are common [87].”
From Animal to human translation: a systematic scoping review of reported concordance rates (2019) · cites this paper as [87]
Citations
Cites
Dose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524 · cited 10×
“62 mg/kg, or;98 mg for a 60 kg human(3, 55).”
BackgroundMethodInfluentialResveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290 · cited 3×
“(51), or any animal model study, into a human equivalent dosage for therapeutic effect.”
BackgroundLagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057 · cited 2×
“Reagan-Shaw’s example for the “inappropriate comparisons between studies” for pharmacologic effect in humans stemmed from the discussion of resveratrol dosage in the literatureandpress (3, 51, 52).”
BackgroundKleiber, M. (1932) · Hilgardia · doi:10.3733/hilg.v06n11p315 · Cited by 2,222 · cited 1×
“The statements by Pinkel that blood volume, circulating plasma proteins, and renal function correlated with a surface law had already been disproven in the literature for over a decade when published in 1958, and there is no reason to perpetuate misinformation by allowing it to stay in themodern literature without pro…”
BackgroundCytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Clinical Methods: The History, Physical, and Laboratory Examinations
Kruse, J. A. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450210108045 · Cited by 2,029
Quantitative Laws in Metabolism and Growth
von Bertalanffy, L. (1957) · The Quarterly Review of Biology · doi:10.1086/401873 · Cited by 2,029 · cited 4×
“The use of allometry for pharmacokinetic prediction originates from work in metabolic scaling, which plotted the formula to fit the metabolic rate and body weight of animals on double logarithmic scale (10, 29, 41).”
BackgroundMethodInfluentialHIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
Kleiber, M. (1947) · Physiological Reviews · doi:10.1152/physrev.1947.27.4.511 · Cited by 1,817 · cited 8×
“In 1947, Kleiber (11) made a reductio ad absurdum argument to discredit the claims of Dreyer and Ray (18, 19), which is equally applicable to Pinkel (17) from 1958 and Reagan-Shaw et al. (3) from 2008.”
BackgroundMethodInfluentialLost in translation: animal models and clinical trials in cancer treatment.
(2014) · Europe PMC (PubMed Central) · Cited by 1,033
Research works printed but not linked: 4
- Center for Drug Evaluation and Research, 2002, Guidance for Industry and Reviewers: Estimating the Safe Starting Dose in Clinical Trials for Therapeutics in Adult Healthy Volunteers, Draft Guidance
- Rubner M., 1883, Über den einfluss der körpergrösse auf stoff- und kraftwechsel, Zeit. Biol., 19, 536
- Center for Drug Evaluation and Research, 2005, Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers
- Mahmood I., 2005, Interspecies Pharmacokinetic Scaling: Principles and Application of Allometric Scaling
Cited by
Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease
Decourt, B., Lahiri, D. K., & Sabbagh, M. N. (2017) · Current Alzheimer Research · doi:10.2174/1567205013666160930110551 · Cited by 371
Animal to human translation: a systematic scoping review of reported concordance rates
Leenaars, C. H. C., Kouwenaar, C., Stafleu, F. R., Bleich, A., Ritskes-Hoitinga, M., De Vries, R. B. M., & Meijboom, F. L. B. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1976-2 · Cited by 314
Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation
Bai, Y., Wang, X., Zhao, S., Ma, C., Cui, J., & Zheng, Y. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/407580 · Cited by 202
“According to the conversion formula between mice and human [87, 88], the consumption of SFN in human is supposed to be 0.”
Vitamin D, Cognition and Alzheimer’s Disease: The Therapeutic Benefit is in the D-Tails
Landel, V., Annweiler, C., Millet, P., Morello, M., & Féron, F. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150943 · Cited by 185
“Deriving interspecies equivalents for therapeutic interventions has usually been done using Body Surface Area scaling; however, it appears that this might not be as adequate as advanced allometric and physiologically based pharmacokinetic modeling for animal-to-human dosage conversion [141].”
MethodBody surface area formulae: an alarming ambiguity
Redlarski, G., Palkowski, A., & Krawczuk, M. (2016) · Scientific Reports · doi:10.1038/srep27966 · Cited by 159
Cisplatin Mouse Models: Treatment, Toxicity and Translatability
Perše, M. (2021) · Biomedicines · doi:10.3390/biomedicines9101406 · Cited by 171
“These differences in pharmacokinetics greatly affect the resulting peak plasma concentration (Cmax) values and exposure derived from area under curve (AUC), which influence the dose response relationship of potential therapeutics” [101].”
BackgroundZhang, C., Wang, X., Wang, C., He, C., Ma, Q., Li, J., Wang, W., Xu, Y., & Wang, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.790072 · Cited by 110
DoseCal: a virtual calculator for dosage conversion between human and different animal species
Janhavi, P., Divyashree, S., Sanjailal, K. P., & Peddha, M. S. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1687523 · Cited by 100
“Certainly, Blanchard and Smoliga (2015) in their review have mentioned that, though BSA has been used widely for the dose conversion even at clinical levels, it is recommended to use scientific physiologic, pharmacokinetic, and toxicologic data to optimise a drug dose rather than based on BSA.”
BackgroundPre-Clinical Testing of Therapies for Traumatic Brain Injury
DeWitt, D. S., Hawkins, B. E., Dixon, C. E., Kochanek, P. M., Armstead, W. M., Bass, C. R., Bramlett, H. M., Büki, A., Dietrich, W. D., Ferguson, A. R., et al. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.5778 · Cited by 93
“Although the BSA conversion has been widely used for many years, Blanchard and Smoliga 79 recently reviewed the evidence that scaling based on BSA also is inadequate due to the evidence that body structures and function that affect drug outcome do not scale only by BSA or body mass.”
Negrette-Guzmán, M. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172513 · Cited by 74
Nutraceuticals, A New Challenge for Medicinal Chemistry
Sut, S., Baldan, V., Faggian, M., Peron, G., & Dall’Acqua, S. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160615104837 · Cited by 70
Resveratrol has anti-thyroid effects both in vitro and in vivo
Giuliani, C., Iezzi, M., Ciolli, L., Hysi, A., Bucci, I., Santo, S. D., Rossi, C., Zucchelli, M., & Napolitano, G. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.06.044 · Cited by 73
Mathé, A. A., Michaneck, M., Berg, E., Charney, D. S., & Murrough, J. W. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa054 · Cited by 67
Liang, Y., Bai, W.-J., Li, C.-G., Xu, L., Wei, H., Pan, H., He, X., & Ouyang, D. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00390 · Cited by 64
“Our results also suggested that piperine might inhibit ATP-induced pyroptosis by suppressing AMPK activation.”
BackgroundResultZhang, V. X., Sze, K. M., Chan, L., Ho, D. W., Tsui, Y., Chiu, Y., Lee, E., Husain, A., Huang, H., Tian, L., et al. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00731-0 · Cited by 60
Korde, A. G., Mikołajczak, R., Peitl, P. K., Bouziotis, P., Westin, H., Lauritzen, M., Koole, M. J. B., Herth, M. M., Bardiès, M., Martins, A. F., et al. (2022) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-022-00168-x · Cited by 56
Systems Biology, Systems Medicine, Systems Pharmacology: The What and The Why
Stéphanou, A., Fanchon, E., Innominato, P. F., & Ballesta, A. (2018) · Acta Biotheoretica · doi:10.1007/s10441-018-9330-2 · Cited by 50
“…according to inter-species in vitro studies, (iv) blood/organ transport and drug clearance parameters are intended to be scaled using physiological information although such methods are still under development (Ballesta et al. 2014; Blanchard and Smoliga 2015; Kang and Lee 2011; Lave et al. 2009).”
BackgroundDexmedetomidine enhances ropivacaine-induced sciatic nerve injury in diabetic rats
Yu, Z., Geng, J., Li, Z. Q., Sun, Y., Wang, S. L., Masters, J., Wang, D., Guo, X., Li, M., & Ma, D. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2018.08.022 · Cited by 49
“The literature on translating doses from animal models to human trials has repeatedly shown that it is far more complex than scaling dosage based on body mass.(34,35) Therefore, it is invalid to assume that a 20 mg kg 1 dose of dexmedetomidine in a rodent is equivalent to a 20 mg kg 1 dose in a human.”
BackgroundDose Selection in Preclinical Studies: Cross-Species Dose Conversion
Шекунова, Е. В., Kovaleva, M. А., Макарова, М. Н., & Makarov, V. G. (2020) · The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · doi:10.30895/1991-2919-2020-10-1-19-28 · Cited by 60
“Например, клинические данные по ФК препарата дерамциклан почти на порядок отличались от значений, которые рассчитывались на основании межвидового переноса доз с учетом различий ППТ [10].”
InfluentialPruett, S. B., Tan, W. F., Howell, G., & Nanduri, B. (2020) · Alcohol · doi:10.1016/j.alcohol.2020.03.011 · Cited by 46
Ni, H., Liu, M., Cao, M., Zhang, L., Zhao, Y., Yi, L., Li, Y., Liu, L., Wang, P., Du, Q., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116190 · Cited by 53
An Introduction to Ecoimmunology
Schoenle, L. A., Downs, C. J., & Martin, L. B. (2018) · Springer eBooks · doi:10.1007/978-3-319-76768-0_26 · Cited by 57
“Drug effects do not scale directly with size, though, but we rarely take this into account when developing human treatment plans (Blanchard and Smoliga 2008; Mahmood et al.”
BackgroundSharman, M. J., Gyengési, E., Liang, H., Chatterjee, P., Karl, T., Li, Q.-X., Wenk, M. R., Halliwell, B. B., Martins, R. N., & Münch, G. W. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.11.026 · Cited by 52
Safety Evaluation and Imaging Properties of Gadolinium-Based Nanoparticles in nonhuman primates
Kotb, S., Agudelo, J. P., Lamberton, F., Lux, F., Verset, M., Cataldo, V. D., Contamin, H., Tillement, O., Canet‐Soulas, E., & Sancey, L. (2016) · Scientific Reports · doi:10.1038/srep35053 · Cited by 47
Liu, H., Wang, Y., Yang, L., Zhou, M. L., Jin, M., Xiao, G.-S., Wang, Y., Sun, H., & Li, G. (2016) · Scientific Reports · doi:10.1038/srep25743 · Cited by 42
da Silva, A. B., Miniter, M., Thom, W. D., Hewitt, R. E., Wills, J. W., Jugdaohsingh, R., & Powell, J. J. (2020) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2020.02.007 · Cited by 47
“Blanchard and Smoliga, 2015; Nair and Jacob, 2016) [26,27].”
BackgroundJhou, J., Chen, S.-J., Huang, H., Lin, W., Huang, D.-Y., & Tzeng, S. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.144 · Cited by 45
Emerging Therapeutic Applications for Fumarates
Hoogendoorn, A., Avery, T. D., Li, J., Bursill, C. A., Abell, A. D., & Grace, P. M. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.01.004 · Cited by 40
Haouzi, P. A., & Tubbs, N. (2022) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00819.2021 · Cited by 44
Zhou, W., Dai, C., Liu, W.-Z., Zhang, C., Zhang, Y., Yang, G., Guo, Q.-H., Li, S., Yang, H., & Li, A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113564 · Cited by 36
Vieira, P. A., Shin, C., Arroyo‐Currás, N., Ortega, G., Li, W., Keller, A. A., Plaxco, K. W., & Kippin, T. E. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00069 · Cited by 41
“Food and Drug Administration nevertheless continues to recommend BSA-based dose scaling from preclinical studies to human trials (Blanchard and Smoliga, 2015), an approach that many scientists and clinicians discourage (Price and Frazier, 1998).”
BackgroundSchidlitzki, A., Bascuñana, P., Srivastava, P. K., Welzel, L., Twele, F., Töllner, K., Käufer, C., Gericke, B., Feleke, R., Meier, M., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104664 · Cited by 39
“human comparisons and prediction of clinically effective drug levels or exposure (Klein et al., 2012b; Blanchard and Smoliga, 2015).”
Is Small Fiber Neuropathy Induced by Gadolinium-Based Contrast Agents?
Radbruch, A., Richter, H., Bücker, P., Berlandi, J., Schänzer, A., Deike‐Hofmann, K., Kleinschnitz, C., Schlemmer, H., Forsting, M., Paulus, W., et al. (2020) · Investigative Radiology · doi:10.1097/rli.0000000000000677 · Cited by 35
Quantifying the limits of CAR T-cell delivery in mice and men
Brown, L., Gaffney, E. A., Ager, A., Wagg, J., & Coles, M. C. (2021) · Journal of The Royal Society Interface · doi:10.1098/rsif.2020.1013 · Cited by 38
“Scaling of dosages of any therapy between animals and humans is often assumed to 26 depend on body mass or (erroneously [18]) surface area [19, 20], but this is complicated for CAR T-cells by the impact 27”
Tou, J. C. L. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12840 · Cited by 37
Gaballah, H. H., Gaber, R. A., & Mohamed, D. A. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.12.012 · Cited by 34
Wu, Y., Sun, L., Zeng, F., & Wu, S. (2018) · Photoacoustics · doi:10.1016/j.pacs.2018.11.002 · Cited by 34
“Polygonum multiflorum (PM) is one of the most popular perennial Chinese herbal medicines, which has been officially listed in the Chinese Pharmacopoeia [46].”
BackgroundShao, W., Xu, J., Xu, C. Y., Weng, Z., Liu, Q., Zhang, X., Liang, J., Li, W., Zhang, Y., Jiang, Z., et al. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.115974 · Cited by 34
Ma, L., Wang, Y., Chen, X., Zhao, L., & Guo, Y. (2020) · Toxicology · doi:10.1016/j.tox.2020.152585 · Cited by 35
Ankul Singh, S., Suresh, S., Singh, A., Chandran, L., & Vellapandian, C. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.120136 · Cited by 34
Tien, Y., Liu, K., Pope, C. A., Wang, P., Ma, X., & Zhong, X. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.066316 · Cited by 35
“pharmacokinetic modeling (Blanchard and Smoliga, 2015) should be applied, but such data are not available for pharmacokinetic modeling of phenobarbital between neonatal mice and humans.”
BackgroundGoggi, J., Hartimath, S. V., Xuan, T. Y., Khanapur, S., Jieu, B., Chin, H. X., Ramasamy, B., Cheng, P. K. C., Rong, T. J., Yong, F., et al. (2021) · Molecular Imaging and Biology · doi:10.1007/s11307-021-01596-y · Cited by 34
Yu, H., Sheen, J., Tiao, M., Tain, Y., Chen, C., Lin, I.-C. F., Lai, Y., Tsai, C., Lin, Y., Tsai, C., et al. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201801385 · Cited by 31
Tang, F., Wong, H. H., & Ng, C. M. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2269 · Cited by 29
Sayed, H. M., Said, M. M., Morcos, N. Y. S., El-Gawish, M. A., & Ismail, A. F. M. (2021) · Integrative Cancer Therapies · doi:10.1177/15347354211021920 · Cited by 35
Xu, Y., Huang, J., Wang, N., Tan, H., Zhang, C., Li, S., Tang, G., & Feng, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.649606 · Cited by 32
“, 2011) and animal studies (Blanchard and Smoliga, 2015; Lv et al., 2019;Wu et al., 2019), we orally administered GQL at 1 g/kg (GQL-L group) and 2 g/kg (GQL-H group) to T2DM mice for six weeks.”
BackgroundYou, M., Li, S., Yan, S., Yao, D., Wang, T., & Wang, Y. (2023) · Environment International · doi:10.1016/j.envint.2023.108228 · Cited by 27
Investigating the multi-target therapeutic mechanism of Guihuang formula on Chronic Prostatitis
Liu, S., Zhao, F., Deng, Y.-J., Yin, Z., Yan, B., Guo, J., & Gao, Q.-H. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115386 · Cited by 26
Wang, T., Xu, H. Y., Wu, S., Guo, Y., Zhao, G., & Wang, D. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c02023 · Cited by 30
Veskoukis, A. S., Γουτιάνος, Γ., Paschalis, V., Margaritelis, N. V., Tzioura, A., Δίπλα, Κ., Zafeiridis, A., Vrabas, I. S., Kyparos, A., & Nikolaidis, M. G. (2016) · European Journal of Applied Physiology · doi:10.1007/s00421-016-3336-8 · Cited by 27
Dual effect of silymarin on experimental non-alcoholic steatohepatitis induced by irinotecan
Assis-Júnior, E. M., de Melo, A. T., Pereira, V. B. M., Wong, D. V. T., de Sousa, N. R. P., Oliveira, C. M. G., Malveira, L. R. C., Moreira, L. S., de Souza, M. H. L. P., de Almeida, P. R. C., et al. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.04.023 · Cited by 25
Ren, P., Yue, H., Tang, Q., Wang, Y., & Xue, C. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111553 · Cited by 25
Lin, E., Li, Z., Huang, Y., Ru, G., & He, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.609290 · Cited by 24
“In the future, physiologic, pharmacokinetic, and toxicology data can also be used for scientific justification (Blanchard and Smoliga, 2015).”
BackgroundZhang, T., Wang, C., Song, A., Xiao, L., Li, G., Sun, H. M., Wang, X., Geng, Z., Shu, G., & Deng, X. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117495 · Cited by 23
Wang, Y., Ullah, M. A., Waltner, O. G., Bhise, S. S., Ensbey, K. S., Schmidt, C. R., Legg, S. R. W., Sekiguchi, T., Nelson, E. L., Kuns, R. D., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci170125 · Cited by 24
“Indeed, there have been previous suggestions that body surface area calculations are more appropriate to convert doses across species whereby 5 mg/kg in humans would equate to approximately 60 mg/kg in mice (30), although these assumptions have also been challenged (31).”
Update on Cancer Treatment in Exotics
Zehnder, A. M., Graham, J. E., & Antonissen, G. (2018) · Veterinary Clinics of North America Exotic Animal Practice · doi:10.1016/j.cvex.2018.01.012 · Cited by 21
“Therefore, dose extrapolation between different animal species should be based on more advanced allometric and physiologically based pharmacokinetic modeling.(146) Recently, Antonissen and colleagues(22) demonstrated by allometric scaling a clear correlation (R(2)>0.”
BackgroundComparative physiology and efficacy of atropine and scopolamine in sarin nerve agent poisoning
Cornelissen, A. S., Klaassen, S. D., van Groningen, T., Bohnert, S., & Joosen, M. J. A. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.114994 · Cited by 21
Bloms-Funke, P., Bankstahl, M., Bankstahl, J., Kneip, C., Schröder, W., & Löscher, W. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108884 · Cited by 19
Liu, T., Yan, T., Jia, X., Liu, J., Ma, R., Wang, Y., Wang, X., Liang, Y., Xiao, Y., & Dong, Y. J. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114847 · Cited by 20
Fan, L., Wu, Y., Li, C., Yan, B., Chen, S., Peng, Q., Yang, X., & Ma, P. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.132392 · Cited by 19
Đurašević, S., Nikolić, G., Zaletel, I. V., Grigorov, I., Memon, L., Mitić-Ćulafić, D., Vujovic, P. Z., Đorđević, J., & Todorović, Z. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103601 · Cited by 22
Shen, G., Shang, Q., Zhang, Z., Zhao, W., Chen, H., Mijiti, I., Chen, G., Yu, X., Yu, F., Zhang, P., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.878963 · Cited by 19
“This method of calculating the rat oral administration dose is similar to previous studies (9, 20).”
Wada, H., Sato, Y., Fujimoto, S., Okamoto, K., Bando, M., Kawaguchi, T., Miyamoto, H., Muguruma, N., Horimoto, K., Matsuzawa, Y., et al. (2022) · Cancer Science · doi:10.1111/cas.15576 · Cited by 21
Li, C., Song, P., Fan, L., Lu, S., Xu, D., Zheng, G., Yang, X., Wu, Y., & Ma, P. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111275 · Cited by 21
Griffin, R., Avery, E., & Xia, C. Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.830972 · Cited by 17
“In fact, there is considerable debate on the degree of correlation (Raegan-Shaw et al., 2007; Blanchard and Smoliga, 2015).”
BackgroundMolecular Imaging of Deoxycytidine Kinase Activity Using Deoxycytidine-Enhanced CEST MRI
Han, Z., Li, Y., Zhang, J., Liu, J., Chen, C., van Zijl, P. C. M., & Liu, G. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3565 · Cited by 17
“It should be noted that the calculated HED by scaling the BSA between different species is only an estimation of the safe starting dose for initial clinical studies(47) and the accurate determination of the safe dose of dC that can be used in human for an imaging purpose needs more insights into physiologic and pharma…”
BackgroundBethi, C. M. S., Kumar, M. N., Kalarikkal, S. P., Janakiraman, N., & Sundaram, G. M. (2025) · Food Chemistry · doi:10.1016/j.foodchem.2025.145088 · Cited by 17
Lv, D., Ji, Y. S., Zhang, Q., Shi, Z., Chen, T., Zhang, C., Wang, X., Ren, T., Gao, Z., & Zhong, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.961011 · Cited by 18
“The dose of MLST intervention in rats was determined based on the human equivalent dose, which was calculated from the body surface area equivalent dose (Blanchard and Smoliga, 2015).”
MethodYan, D., Gao, L., Lang, J., Gao, X., & Ma, H. (2021) · Environmental Toxicology · doi:10.1002/tox.23294 · Cited by 17
“Mn toxicity has been observed in adults receiving doses in excess of 500 μg/d.1 The highest dose of Mn (200 μmol/kg) used in this study was equivalent to a human dose of 440 μg/kg bw/d, as calculated according to the dose conversion method reported by Reagan-Shaw et al.25,26 Furthermore, Mn can cross the blood–brain b…”
MethodYang, H., Xu, G., Zhang, C., Sun, J., Zhang, Y., Song, J., Li, Y., Liu, Y., & Li, A. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4410 · Cited by 17
“3) for translating dosages from human to animal (19,20), the clinical dosage of G.”
BackgroundNAD+ Therapeutics and Skeletal Muscle Adaptation to Exercise in Humans
Campelj, D. G., & Philp, A. (2022) · Sports Medicine · doi:10.1007/s40279-022-01772-2 · Cited by 20
“Differences in the impact of NR supplementation between animals and human studies may also be influenced by the scale of dosing between species [56] and the dosing strategy [14], i.”
BackgroundRisen, S. J., Kusick, B. R., Sharma, S., Gilberto, V. S., Brindley, S., Aguilar, M., Brown, J. M., McGrath, S., Chatterjee, A., Moreno, J. A., et al. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00068 · Cited by 13
Tao, W., Yue, X., Ye, R., Nabi, F., Shang, Y., Zhu, Z., Ahmed, B. Z., & Liu, J. (2022) · Animals · doi:10.3390/ani12050569 · Cited by 15
“The herbal dosages of PCPE were measured based on human and animal body weight and according to Research and Evaluation of Pharmacodynamics [20].”
MethodXiao, X., Zhong, Z., Wei, C., Wang, G., Zhao, Z., He, J., Zhai, Z., Zhou, Y., Wang, W., Guo, H., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202411426 · Cited by 18
Guo, X., Wang, J., Niu, R., Li, R., Wang, J., Fan, X., Wang, X., & Sun, Z. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105334 · Cited by 15
Ma, X., Yu, X., Min, J., Chen, X., Liu, R., Cui, X., Cheng, J., Xie, M., Diel, P. R., & Hu, X. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.11.013 · Cited by 13
Dai, C., Li, M., Sun, T., Zhang, Y., Wang, Y., Shen, Z., Velkov, T., Tang, S., & Shen, J. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.112966 · Cited by 16
Hu, H.-F., Wang, Z., Tang, W., Fu, X.-M., Kong, X., Qiu, Y., & Xi, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1047507 · Cited by 14
Overgaard, N. H., Frøsig, T. M., Jakobsen, J. T., Buus, S., Andersen, M. H., & Jungersen, G. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.08.057 · Cited by 14
“However, the BSA method still shows extreme inaccuracy [7]; suggesting the need for further improvement in strategies converting animal”
MethodLiu, C.-T., Kao, L., Shih, J., Chien, W., Chiu, C., Ma, K., Huang, Y., Cheng, C., Shiue, C., & Li, I. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172639 · Cited by 14
Li, N., Zhang, E., Zhang, J., Zhang, L., Liu, Y.-E., Jin, H., Gao, Y., & Hou, L. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106280 · Cited by 14
Li, Y., Hintze, K. J., & Ward, R. E. (2021) · Biochimie · doi:10.1016/j.biochi.2021.02.010 · Cited by 17
“47 useful for determining safe starting doses in humans, and not pharmacologically active doses [60].”
BackgroundAntonissen, G., & Martel, A. (2018) · Veterinary Clinics of North America Exotic Animal Practice · doi:10.1016/j.cvex.2018.01.009 · Cited by 16
Chronobiotic and cytoprotective activity of melatonin in the cardiovascular system. Doses matter
Cardinali, D. P., & Vigo, D. E. (2024) · npj Biological Timing and Sleep · doi:10.1038/s44323-024-00007-z · Cited by 18
“In all cases the human equivalent dose (HED) for a 75 kg adult was calculatedbynormalizingbodysurfaceareafromanimal doses 188 – 190 .”
Melatonin as a Chronobiotic and Cytoprotector in Non-communicable Diseases: More than an Antioxidant
Cardinali, D. P., Pandi-Perumal, S. R., & Brown, G. M. (2024) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-66768-8_11 · Cited by 15
Davoli, P., Floriani, M., Assisi, F., Kob, K., & Sitta, N. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201406655 · Cited by 12
Smoliga, J. M., & Blanchard, O. L. (2017) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v7i5.345 · Cited by 11
“literature and its recommendations are unjustified [28].”
Self-citationQuantitative Measurements of Pharmacological and Toxicological Activity of Molecules
Kazakova, R. R., & Masson, P. (2022) · Chemistry · doi:10.3390/chemistry4040097 · Cited by 11
“Although translations of LD50 from animals to humans have been criticized [22], calculated LD50 values provide an estimate of chemical toxicity in humans.”
BackgroundBaicalin Enhanced Oral Bioavailability of Sorafenib in Rats by Inducing Intestine Absorption
Wei, J., Liu, R., Zhang, J., Liu, S., Yan, D., Wen, X., & Tian, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.761763 · Cited by 11
Ma, Y., Xu, H., Chen, G., Liu, W., Ma, C., Meng, J., Yuan, L., Hua, X., Ge, G., & Lei, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1186699 · Cited by 10
Acacetin as a natural cardiovascular therapeutic: mechanisms and preclinical evidence
Zhou, Z., Li, T., Qin, H., Wang, X., He, S., Fan, Z., Ye, Q., & Du, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1493981 · Cited by 14
Popović, K. J., Popović, D. J., Miljković, D., Popović, J. K., Lalošević, D., Poša, M., & Čapo, I. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112168 · Cited by 10
Acute and Subchronic Toxicological Evaluation of the Herbal Product HAD-B1 in Rats
Park, S.-J., Kim, S.-D., Kwag, E.-B., Park, J. H., & Yoo, H. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/9970822 · Cited by 10
“In terms of dose translation from animals to humans, the human equivalent dose (HED; animal dose (mg/kg) × (animal Km factor/human Km factor)) calculated using the body surface area (mg/m(2)) for initial clinical trials in healthy adult volunteers [15, 16] was 324.”
MethodLiu, Y., Zhang, C., Liu, Y. F., Zhu, J., Qu, H., Zhou, S., Chen, M., Xu, D., Chen, L., & Wang, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315081 · Cited by 13
“17), to make sure that the exposure dose of each exogenous substance was lower than the daily intake [48,49].”
BackgroundShin, H.-S., Kindleysides, S., Yip, W. C. Y., Budgett, S. C., Ingram, J. R., & Poppitt, S. D. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0085-1 · Cited by 9
“Body surface area (BSA) normalisation algorithms [43], albeit a simple approach to dose conversion [44], show this to be to a human equivalent dose (HED) of ~350–1,000 mg in a 60 kg adult (HED, mg/kg = rodent dose, mg/kg × [rodent Km/human Km], where mouse Km = 3, rat Km = 6, human Km = 37), and indicate that sufficie…”
BackgroundRen, P., Tang, Q., He, X., Xu, J., Wang, Y., & Xue, C. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300569 · Cited by 9
Zhao, X., Li, J., Li, T., Pan, C., Xue, F., & Wang, G. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10448 · Cited by 9
Jia, Z., Lv, D., Chen, T., Shi, Z., Li, X., Ma, J., Gao, Z., & Zhong, C. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29975 · Cited by 9
“…the low-, medium-and high-dose groups (0.22 g/kg 、 0.44 g/kg and 0.88 g/kg, 0.5, 1 and 2 times the clinical dose, respectively, reckon the dosage of QLJD intervention in rats by converting the human equivalent dose to rat equivalent dose based on body surface area [28]), with 6 rats in each group.”
MethodInfluentialAisha Siddiq, A., Abduldileep, S., Rao, S. J. A., Singam, S. S. R., & Martin, A. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119697 · Cited by 9
GLP-1 receptor agonists show no detrimental effect on sperm quality in mouse models and cell lines
Yin, D., Li, F., Li, X., Wei, T., Shan, C., Zhang, Z., & Wei, R. (2025) · Endocrine · doi:10.1007/s12020-025-04245-4 · Cited by 12
“Besides, the dose of 0.2 mg/kg was equal to the dose of 0.7 mg/kg in human based on the Meeh-Rubner body surface area calculation [14], and this dose was among the commonly used dose in human (0.6 mg – 1.8 mg) [14, 15].”
Influential
Metadata
- Authors
- Blanchard, O. L., & Smoliga, J. M.
- Affiliations
- Wilmore Labs Limited Liability Company San Antonio Texas USA
- High Point University (US)
- Corresponding author
- Smoliga, James M.
- ORCID
- Smoliga, James M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2015-02-05
- Volume
- 29
- Issue
- 5
- Pages
- 1629-1634
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2032445654
- Cited by
- 183
- References
- 61
- Citations by year
- 2026: 23 · 2025: 27 · 2024: 16 · 2023: 14 · 2022: 22 · 2021: 22 · 2020: 14 · 2019: 13 · 2018: 7 · 2017: 8 · 2016: 11 · 2015: 6
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Keywords
- interspecies scaling, resveratrol, human equivalent dose, allometric scaling, physiologically based pharmacokinetic modeling, drug dosing, translational medicine, adverse drug reactions
- MeSH terms
- Animals, Body Surface Area, Clinical Trials as Topic, Dose-Response Relationship, Drug, Humans, Species Specificity, Therapeutic Equivalency, Tissue Distribution, Drugs, Investigational, Models, Animal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.